Abrente Lifesciences Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2015.
2015 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Abrente Lifesciences Private Limited

Abrente Lifesciences Private Limited, a active private limited company, was established on 12 October 2015 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74999MH2015PTC269098. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.50 M.

It upholds a compliant status. Its leadership includes Akshay Jain (Director), Rohit Devidayal Mittal (Director), Sandeep Raj (Director). Past directors included Nardev Singh, Akshay Jain, Pranav Parduman Goyal. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C-201, Kanti Apartments,Near Mount Mary Church Mount Mary Road, Bandra (West), Mumbai, Maharashtra, 400050.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2015PTC269098

  • Registration Number

    269098

  • Incorporation Date

    12 October 2015

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹2.50 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 2.50 M
  • Company Age 10 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 6.48%
  • Profit Growth **** -44.60%
  • Ebitda **** -193.15%
  • Net Worth 7.18%
  • Total Assets -5.72%
Company report

Abrente Lifesciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Abrente Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Abrente Lifesciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Akshay Jain Director 13 Feb 2018 Current
Rohit Devidayal Mittal Director 13 Feb 2018 Current
Sandeep Raj Director 17 Apr 2025 Current
Neena Aksay Jain Additional Director 01 Jan 2026 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2017 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Director 04 Jun 2018 Past
Pramod Abcsdd Director 04 Jun 2018 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Abrente Lifesciences.

Abrente Lifesciences Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 6.48% increase. The company also saw a substantial fall in profitability, with a 44.6% decrease in profit. The company's net worth moved up by a moderate rise of 7.18%.

Abrente Lifesciences revenue growth over time
Abrente Lifesciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 6.48%
*******
*******
*******
*******
Revenue from Operations
*******
 6.33%
*******
*******
*******
*******
Total Assets
*******
 -5.72%
*******
*******
*******
*******
Profit or Loss
*******
 -44.60%
*******
*******
*******
*******
Net Worth
*******
 7.18%
*******
*******
*******
*******
EBITDA
*******
 -193.15%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Abrente Lifesciences?

In 2019, Abrente Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Abrente Lifesciences?

Unlock and access historical data on people associated with Abrente Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Abrente Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abrente Lifesciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Abrente Lifesciences
Recent Activity within the Organization
  • Director Appointment

    Progress on Neena Aksay Jain was appointed as a Additional Director was appointed as a Additional Director on 01 Jan 2026 & has been associated with this company since 1 month 24 days . was documented.

  • Annual General Meeting

    Abrente Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Sandeep Raj was appointed as a Director was appointed as a Director on 17 Apr 2025 & has been associated with this company since 10 months 10 days . was recorded as a recent event.

  • Balance Sheet

    The activity Abrente Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was completed.

  • Director Appointment

    The activity Akshay Jain was appointed as a Director was appointed as a Director on 13 Feb 2018 & has been associated with this company since 8 years 12 days . was completed.

  • Director Appointment

    The activity Rohit Devidayal Mittal was appointed as a Director was appointed as a Director on 13 Feb 2018 & has been associated with this company since 8 years 12 days . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Abrente Lifesciences Private Limited?

The CIN of Abrente Lifesciences Private Limited is U74999MH2015PTC269098.

Where is Abrente Lifesciences Private Limited headquartered?

Abrente Lifesciences Private Limited is headquartered at C-201, Kanti Apartments,Near Mount Mary Church Mount Mary Road, Bandra (West), Mumbai, Maharashtra, 400050.

When was Abrente Lifesciences Private Limited incorporated?

Abrente Lifesciences Private Limited was incorporated on 12 October 2015.

Who are the current directors of Abrente Lifesciences Private Limited?

The current directors of Abrente Lifesciences Private Limited are

What is the primary industry of Abrente Lifesciences Private Limited?

The primary industry of Abrente Lifesciences Private Limited is Pharma.

Is Abrente Lifesciences Private Limited a listed company?

Abrente Lifesciences Private Limited is unlisted.

What is the capital structure of Abrente Lifesciences Private Limited?

The authorized capital of Abrente Lifesciences Private Limited is ₹3.00 M, and the paid-up capital is ₹2.50 M.

What is the compliance status of Abrente Lifesciences Private Limited?

The compliance status of Abrente Lifesciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available